The Impact of Patents on Innovation, Technology Transfer and Health: A Pre- and Post-TRIPs Analysis of India's Pharmaceutical Industry

References

• Abbott, F.M., Kapczynski, A. and Srinivasan, T.N. (2005), ‘The Draft Patent Law’, The Hindu, 12 March. Available from: http://www.thehindu.com/2005/03/12/stories/2005031201151000.htm [accessed 17 September 2012].
   Google Scholar
• Abrol, D.Prajapati, P.Singh, N. (2011), ‘Globalization of the Indian Pharmaceutical Industry: Implications for Innovation’, International Journal of Institutions and Economies, 3 (2), pp. 327–65.
   Google Scholar
• Amin, A.Cohendet, P. (2005), ‘Geographies of Knowledge Formation in Firms’, Industry and Innovation, 12 (4), pp. 465–86. doi: 10.1080/13662710500381658
   Google Scholar
• Andersen, T. (2010), ‘Tide Turns for Drug Manufacturing in Africa’, The Lancet, 375 (9726), pp. 1597–8. doi: 10.1016/S0140-6736(10)60687-3
   PubMedGoogle Scholar
• Athreye, S.Kale, D.Ramani, S. (2009), ‘Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector’, Industrial and Corporate Change, 18 (4), pp. 729–59. doi: 10.1093/icc/dtp024
   Web of Science ®Google Scholar
• Bathelt, H.Malmberg, A.Maskell, P. (2004), ‘Clusters and Knowledge: Local Buzz, Global Pipelines and the Process of Knowledge Creation’, Progress in Human Geography, 28 (1), pp. 31–56. doi: 10.1191/0309132504ph469oa
   Web of Science ®Google Scholar
• Bhagwati, J. (2002), ‘Intellectual Property Protection and Medicines’, The Financial Times, 17 September. Available from: http://www.columbia.edu/~jb38/papers/pdf/FT_Submission_on_IP_Medicines.pdf [accessed 13 October 2012].
   Google Scholar
• Bhaumik, S.Biswas, T. (2012), ‘From Outlier to Trendsetter’, Canadian Medical Association Journal, 184 (12), pp. E635–6. doi: 10.1503/cmaj.109-4246
   Google Scholar
• Bidwai, P. (1995), ‘One Step Forward, Many Steps Back: Dismemberment of India's National Drug Policy’, Development Dialogue, 1 (1), pp. 193–222.
   Google Scholar
• Carlaw, K.,et al. (2006), ‘Beyond the Hype: Intellectual Property and the Knowledge Society/Knowledge Economy’, Journal of Economic Surveys, 20 (4), pp. 633–90. doi: 10.1111/j.1467-6419.2006.00262.x
   Web of Science ®Google Scholar
• Chandler, A. (2005), Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries (Cambridge, MA: Harvard University Press).
   Google Scholar
• Chang, H.J. (2001), ‘Intellectual Property Rights and Economic Development – Historical Lessons and Emerging Issues’, Journal of Human Development, 2 (2), pp. 287–309. doi: 10.1080/14649880120067293
   Google Scholar
• Chang, H.-J. (2004), ‘Regulation of Foreign Investment in Historical Perspective’, The European Journal of Development Research, 16 (3), pp. 687–715. doi: 10.1080/0957881042000266660
   Google Scholar
• Chaudhuri, S. (1984), ‘Manufacturing Drugs Without TNCs: Status of Indigenous Sector in India’, Economic and Political Weekly, 19 (31/33), pp. 1341–83.
   Google Scholar
• Chaudhuri, S. (2005), The WTO and India's Pharmaceutical Industry: Patent Protection, TRIPs and Developing Countries (New Delhi: Oxford University Press).
   Google Scholar
• Chaudhuri, S. (2011), Multinationals and Monopolies: Pharmaceutical Industry in India after TRIPs (Kolkata: Indian Institute of Management Calcutta).
   Google Scholar
• Chaudhuri, S.Goldberg, P.Jia, P. (2006), ‘Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India’, American Economic Review, 96 (5), pp. 1477–514. doi: 10.1257/aer.96.5.1477
   PubMed Web of Science ®Google Scholar
• Chaudhuri, S., Mackintosh, M. and Mujinja, P. (2010a), ‘Indian Generics Producers, Access to Essential Medicines and Local Production in Africa: An Argument with Reference to Tanzania’, European Journal of Development Research, 22 (4), pp. 451–68.
   Google Scholar
• Chaudhuri, S.Park, C.Gopakumar, K. (2010b), Five Years into the Product Patent Regime: India's Response (New York: United Nations Development Programme).
   Google Scholar
• Chittoor, R.,et al. (2008), ‘Strategic Responses to Institutional Changes: ‘Indigenous growth’ Model of the Indian Pharmaceutical Industry’, Journal of International Management, 14 (3), pp. 252–69. doi: 10.1016/j.intman.2008.05.001
   Web of Science ®Google Scholar
• Cimoli, M., Dosi, G. and Stiglitz, J. (2008), The Political Economy of Capabilities Accumulation: The Past and Future of Policies for Industrial Development (Pisa: Laboratory of Economics and Management working paper series, Sant'Anna School of Advanced Studies), 2008/15.
   Google Scholar
• Cimoli, M., et al. (2011), Innovation, Technical Change and Patents in the Development Process (Pisa: Laboratory of Economics and Management working paper series, Sant'Anna School of Advanced Studies), 2011/06.
   Google Scholar
• Cohen, D.M.Levinthal, D.A. (1990), ‘Absorptive Capacity: A New Perspective on Learning and Innovation’, Administrative Science Quarterly, 35 (1), pp. 128–52. doi: 10.2307/2393553
   Web of Science ®Google Scholar
• Commission on Intellectual Property Rights (2002), Integrating Intellectual Property Rights and Development Policy (London: Commission on Intellectual Property Rights).
   Google Scholar
• Cooke, P. (2005), ‘Regionally Asymmetric Knowledge Capabilities and Open Innovation: Exploring ‘Globalisation 2’ – A New Model of Industry Organization’, Research Policy, 34 (8), pp. 1128–49. doi: 10.1016/j.respol.2004.12.005
   Web of Science ®Google Scholar
• Correa, C. (2000), Intellectual Property Rights, the WTO and Developing Countries: The TRIPs Agreement and Policy Options (New York: Zed Books).
   Google Scholar
• D'Adesky, A.C. (2004), Moving Mountains: The Race to Treat Global AIDS (London: Verso).
   Google Scholar
• Das, K. (2003), The Domestic Politics of TRIPs: Pharmaceutical Interests, Public Health, and NGO Influence in India, Gujarat Institute of Development Research, Ahmedabad. Available from: http://www.ppl.nl/bibliographies/wto/files/2913.pdf [accessed 15 October 2012].
   Google Scholar
• Department of Pharmaceuticals (2012), Annual Report 2011–12 (New Delhi: Ministry of Chemicals and Fertilizers, Government of India).
   Google Scholar
• Drahos, P.Braithwaite, J. (2002), Information Feudalism: Who Owns the Knowledge Economy? (New Delhi: Oxford University Press).
   Google Scholar
• Dr Reddy's Laboratories (2005), Annual Report 2004–05 (Hyderabad: Dr Reddy's Laboratories).
   Google Scholar
• European Business and Technology Sector (2012), Indian Biotechnology Sector – Overview. Available from: http://www.ebtc.eu/pdf/Indian_Biotechnology_Sector-Overview_VO1.pdf [accessed 20 August 2012].
   Google Scholar
• Evans, P. (2004), ‘Development as Institutional Change: the Pitfalls of Monocropping and Potentials of Deliberation’, Studies in Comparative International Development, 38 (4), pp. 30–53.
   Google Scholar
• Farole, T.Rodriguez-Pose, A.Storper, M. (2011), ‘Human Geography and the Institutions That Underlie Economic Growth’, Progress in Human Geography, 35 (1), pp. 58–80. doi: 10.1177/0309132510372005
   Web of Science ®Google Scholar
• Felker, G., Chaudhuri, S. and Gyorgy, K. (1997), The Pharmaceutical Industry in India and Hungary: Policies, Institutions, and Technological Development (Washington, DC: The World Bank), World Bank Technical Paper No. 392.
   Google Scholar
• Fink, C.Maskus, K. (2005), Intellectual Property and Development: Lessons from Economic Research (Washington, DC: The World Bank/Oxford University Press).
   Google Scholar
• Fischer, M.Scherngell, T.Jansenberger, E. (2009), ‘Patents, Patent Citations and the Geography of Knowledge Spillovers in Europe’, in C. Karlsson et al. (eds), New Directions in Regional Economic Development: Advances in Spatial Science, 331–45.New York: Springer).
   Google Scholar
• Gertler, M. (2003), ‘Tacit Knowledge and the Economic Geography of Context, or the Undefinable Tacitness of Being (There)’, Journal of Economic Geography, 3 (1), pp. 75–99. doi: 10.1093/jeg/3.1.75
   Web of Science ®Google Scholar
• Gertler, M.Levitte, Y. (2005), ‘Local Nodes in Global Networks: The Geography of Knowledge Flows in Biotechnology Innovation’, Industry and Innovation, 12 (4), pp. 487–507. doi: 10.1080/13662710500361981
   Google Scholar
• Gopakumar, K. (2010), ‘Product Patents and Access to Medicines in India: A Critical Review of the Implementation of TRIPS Patent Regime’, The Law and Development Review, 3 (2), pp. 325–68.
   Google Scholar
• Gray, A. (2004), Access to Medicines and Drug Regulation in Developing Countries: A Resource Guide for DFID (London: DFID Health Systems Resource Centre).
   Google Scholar
• Guennif, S.Ramani, S. (2012), ‘Explaining Divergence in Catching-Up in Pharma Between India and Brazil Using the NSI Framework’, Research Policy, 41 (2), pp. 430–41. doi: 10.1016/j.respol.2011.09.005
   Web of Science ®Google Scholar
• Haakonsson, S.J.Jensen, P.D.O.Mudambi, S.M. (forthcoming), ‘A Co-evolutionary Perspective on the Drivers of International Sourcing of Pharmaceutical R&D to India’, Journal of Economic Geography, doi: 10.1093/jeg/lbs018
   Web of Science ®Google Scholar
• Hamied, Y. (1988), ‘The Indian Patents Act 1970 and the Pharmaceutical Industry’, in N. Nand (ed.) Conquest by Patent: On Patent Law and Policy (New Delhi: National Working Group on Patent Laws. Chapter 15
   Google Scholar
• Hamied, Y. (2005), ‘Indian Pharma Industry – Decades of Struggle and Achievement’, presentation on the occasion of Dr A.V. Rama Rao's 70th birthday, Hyderabad, 2 April.
   Google Scholar
• Harris, R. (2001), ‘The Knowledge-Based Economy: Intellectual Origins and New Economic Perspectives’, International Journal of Management Reviews, 3 (1), pp. 21–40. doi: 10.1111/1468-2370.00052
   Web of Science ®Google Scholar
• Howells, J. (2002), ‘Tacit Knowledge, Innovation and Economic Geography’, Urban Studies, 39 (5–6), pp. 871–84. doi: 10.1080/00420980220128354
   Web of Science ®Google Scholar
• Howells, J. (2012), ‘The Geography of Knowledge: Never So Close but Never So Far Apart’, Journal of Economic Geography, 12 (5), pp. 1003–20. doi: 10.1093/jeg/lbs027
   Web of Science ®Google Scholar
• Jaffe, A.Trajtenberg, R.Henderson, R. (1993), ‘Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations’, Quarterly Journal of Economics, 108 (3), pp. 577–98. doi: 10.2307/2118401
   Web of Science ®Google Scholar
• Joseph, R.K. (2011), The R&D Scenario in Indian Pharmaceutical Industry (New Delhi: Research and Information System for Developing Countries), RIS Discussion Papers No. 176.
   Google Scholar
• Kale, D.Little, S. (2007), ‘From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry’, Technology Analysis & Strategic Management, 19 (5), pp. 589–609. doi: 10.1080/09537320701521317
   Web of Science ®Google Scholar
• Kale, D.Little, S. (2009), ‘International Migration, Knowledge Diffusion and Innovation Capabilities in the Indian Pharmaceutical Industry’, New Technology, Work and Employment, 24 (3), pp. 260–76. doi: 10.1111/j.1468-005X.2009.00233.x
   Google Scholar
• Khan, B.Sokoloff, K. (2001), ‘History Lessons: The Early Development of Intellectual Property Institutions in the United States’, Journal of Economic Perspectives, 15 (3), pp. 233–46. doi: 10.1257/jep.15.3.233
   Web of Science ®Google Scholar
• Kiran, R.Mishra, S. (2011), ‘Research and Development, Exports and Patenting in the Indian Pharmaceutical Industry: A Post TRIPS Analysis’, Eurasian Journal of Business and Economics, 4 (7), pp. 53–67.
   Google Scholar
• Kochanek, S. (1974), Business and Politics in India (Los Angeles: University of California Press).
   Google Scholar
• Kumar, N. (2003), ‘Intellectual Property Rights, Technology and Economic Development: Experiences of Asian Countries’, Economic and Political Weekly, 38 (3), pp. 209–26.
   Google Scholar
• Lal, H. (1990), Drugs Industry, Social Responsibility and the Multinationals (New Delhi: Commonwealth Publishers).
   Google Scholar
• Lall, S. (1974), ‘The International Pharmaceutical Industry and Less-Developed Countries, with Special Reference to India’, Oxford Bulletin of Economics and Statistics, 36 (3), pp. 143–72. doi: 10.1111/j.1468-0084.1974.mp36003002.x
   Google Scholar
• Lall, S. (2003), ‘Indicators of the Relative Importance of IPRs in Developing Countries’, Research Policy, 32 (9), pp. 1657–80. doi: 10.1016/S0048-7333(03)00046-5
   Web of Science ®Google Scholar
• Lanjouw, J.O. (1997), The Introduction of Pharmaceutical Product Patents in India: ‘Heartless Exploitation of the Poor and Suffering’? (New Haven, CT: Yale University), Economic Growth Center discussion paper no. 775.
   Google Scholar
• Lincoln, A. (1894 [1859]), ‘Discoveries, Inventions, and Improvements’ lecture, in J.G. Nicholay and J. Hay (eds), Abraham Lincoln: Complete Works Vol. 1 (New York: Tandy-Thomas), pp. 521–8.
   Google Scholar
• Maira Committee (2011), FDI Policy in Indian Pharma Sector, draft for discussion at the high level committee meeting, New Delhi, Government of India, 27 September. Available from: http://donttradeourlivesaway.files.wordpress.com/2012/06/maira-committee-report.pdf [accessed 5 October 2011].
   Google Scholar
• Malecki, E.J. (2010), ‘Everywhere? The Geography of Knowledge’, Journal of Regional Science, 50 (1), pp. 493–513. doi: 10.1111/j.1467-9787.2009.00640.x
   Web of Science ®Google Scholar
• Malmberg, A.Maskell, P. (2002), ‘The Elusive Concept of Localization Economies: Towards a Knowledge-Based Theory of Spatial Clustering’, Environment and Planning A, 34 (3), pp. 429–49. doi: 10.1068/a3457
   Web of Science ®Google Scholar
• Mansfield, E. (1994), Intellectual Property Protection, Foreign Direct Investment, and Technology Transfer (Washington, DC: The World Bank), International Finance Corporation discussion paper 19. Available from: http://www.bvindecopi.gob.pe/colec/emansfield2.pdf [accessed 17 July 2012].
   Google Scholar
• Maskus, K. (2000), ‘Intellectual Property Rights and Economic Development’, Case Western Reserve Journal of International Law, 32, 471–506.
   Google Scholar
• Morgan, K. (2004), ‘The Exaggerated Death of Geography: Learning, Proximity and Territorial Innovation Systems’, Journal of Economic Geography, 4 (1), pp. 3–21. doi: 10.1093/jeg/4.1.3
   Web of Science ®Google Scholar
• Morrison, A. (2008), ‘Gatekeepers of Knowledge Within Industrial Districts: Who They Are, How They Interact’, Regional Studies, 42 (6), pp. 817–35. doi: 10.1080/00343400701654178
   Web of Science ®Google Scholar
• Muzaka, V. (2009), ‘Shaping Global Rules: Proprietary Pharmaceutical Companies as Global Political Actors’, New Political Economy, 14 (2), pp. 289–301. doi: 10.1080/13563460902826039
   Web of Science ®Google Scholar
• Narayana, P.L. (1984), The Indian Pharmaceutical Industry: Problems and Prospects (New Delhi: National Council of Applied Economic Research).
   Google Scholar
• Patel, S. (1983), ‘Third World Initiatives on Pharmaceuticals: A Documentation for the Record’, IDS Bulletin, 14 (4), pp. 71–8. doi: 10.1111/j.1759-5436.1983.mp14004011.x
   Google Scholar
• Patel, S. (1989), ‘Intellectual Property Rights in the Uruguay Round: A Disaster for the South?’, Economic and Political Weekly, 24 (18), pp. 978–93.
   Google Scholar
• Patel, S. (1992), ‘Statement to the Group of Ministers on Arthur Dunkel's Draft of the Final Act on Uruguay Round of GATT Negotiations’, Social Scientist, 20 (1/2), pp. 99–107. doi: 10.2307/3517540
   Google Scholar
• Paul, S.,et al. (2010), ‘How to Improve R&D Productivity: The Pharmaceutical Industry's Grand Challenge’, Nature Reviews Drug Discovery, 9 (3), pp. 203–14.
   PubMed Web of Science ®Google Scholar
• Perkins, R.Neumayer, E. (2011), ‘Transnational Spatial Dependencies in the Geography of Non-resident Patent Filings’, Journal of Economic Geography, 11 (1), pp. 37–60. doi: 10.1093/jeg/lbp057
   Web of Science ®Google Scholar
• Quick, J. (2003), ‘Essential Medicines Twenty-Five Years On: Closing the Access Gap’, Health Policy and Planning, 18 (1), pp. 1–3. doi: 10.1093/heapol/18.1.1
   PubMed Web of Science ®Google Scholar
• Rai, R.K. (2008), ‘Effect of the TRIPS-Mandated Intellectual Property Rights on Foreign Direct Investment in Developing Countries: A Case Study of the Indian Pharmaceutical Industry’, The Journal of World Intellectual Property, 11 (5–6), pp. 404–31. doi: 10.1111/j.1747-1796.2008.00340.x
   Google Scholar
• Ramanna, A. (2004), Interest Groups and Patent Reform in India (Mumbai: Indira Gandhi Institute of Development Research), working paper 2003–06.
   Google Scholar
• Roderick, P.Pollock, A. (2012), ‘India's Patent Laws under Pressure’, The Lancet, 380 (9846), pp. e2–4. doi: 10.1016/S0140-6736(12)61513-X
   Google Scholar
• Rodrik, D. (2006), ‘Goodbye Washington Consensus, Hello Washington Confusion? A Review of the World Bank's Economic Growth in the 1990s: Learning from a Decade of Reform’, Journal of Economic Literature, 44 (4), pp. 973–87.
   Google Scholar
• Roemer-Mahler, A. (2013), ‘Business Conflict and Global Politics: The Pharmaceutical Industry and the Global Protection of Intellectual Property Rights’, Review of International Political Economy, 20 (1), pp. 121–52. doi: 10.1080/09692290.2011.645848
   Web of Science ®Google Scholar
• Ryan, M. (1998), Knowledge Diplomacy: Global Competition and the Politics of Intellectual Property (Washington, DC: Brookings Institution Press).
   Google Scholar
• Sampat, S.Shadlen, K.Amin, T. (2012), ‘Challenges to India's Pharmaceutical Patent Laws’, Science, 337 (6093), pp. 414–5. doi: 10.1126/science.1224892
   PubMed Web of Science ®Google Scholar
• Saxenian, A.Hsu, J.Y. (2001), ‘The Silicon Valley–Hsinchu Connection: Technical Communities and Industrial Upgrading’, Industrial and Corporate Change, 10 (4), pp. 893–920. doi: 10.1093/icc/10.4.893
   Google Scholar
• Sell, S.Prakash, A. (2004), ‘Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights’, International Studies Quarterly, 48 (1), pp. 143–75. doi: 10.1111/j.0020-8833.2004.00295.x
   Web of Science ®Google Scholar
• Shadlen, K. (2004), ‘Patents and Pills, Power and Procedure: The North-South Politics of Public Health in the WTO’, Studies in Comparative International Development, 39 (3), pp. 76–108. doi: 10.1007/BF02686283
   Web of Science ®Google Scholar
• Shadlen, K. (2009), ‘The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies’, Comparative Politics, 42 (1), pp. 41–58. doi: 10.5129/001041509X12911362972791
   Web of Science ®Google Scholar
• Shadlen, K. (2012), ‘The Mexican Exception: Patents and Innovation Policy in a Non-conformist and Reluctant Middle Income Country’, European Journal of Development Research, 24 (2), pp. 300–18. doi: 10.1057/ejdr.2012.9
   Google Scholar
• Singh, P. (1988), ‘Intellectual Property Rights and the Pharmaceutical Industry’, in N. Nand (ed.), Conquest by Patent: On Patent Law and Policy (New Delhi: National Working Group on Patent Laws), Chapter 14.
   Google Scholar
• Smith, S.E. (2000), Opening Up the World: India's Pharmaceutical Companies Prepare for 2005 (Stanford, CA: Asia/Pacific Research Center, Stanford University).
   Google Scholar
• South Commission on the Uruguay Round (1988), Trade-Related Intellectual Property Rights (Mexico City: South Commission on the Uruguay Round).
   Google Scholar
• Stiglitz, J.E. (2009), ‘Trade Agreements and Health in Developing Countries’, The Lancet, 373 (9661), pp. 363–5. doi: 10.1016/S0140-6736(08)61772-9
   PubMed Web of Science ®Google Scholar
• The New York Times (2005), ‘AIDS Drugs Threatened’, The New York Times, New York, 5 March. Available from: http://www.nytimes.com/2005/03/05/opinion/05sat3.html?_r=0 [accessed 7 October 2012].
   Google Scholar
• t'Hoen, E.,et al. (2011), ‘Driving a Decade of Change: HIV/AIDS, Patents and Access to Medicines for All’, Journal of the International AIDS Society, 14 (1), pp. 1–15. doi: 10.1186/1758-2652-14-15
   PubMedGoogle Scholar
• Trouiller, P.,et al. (2002), ‘Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure’, The Lancet, 359 (9324), pp. 2188–94. doi: 10.1016/S0140-6736(02)09096-7
   PubMed Web of Science ®Google Scholar
• Viotti, E. (2001), National Learning Systems: A New Approach on Technical Change in Late Industrializing Economies and Evidences from the Cases of Brazil and South Korea (Cambridge, MA: Center for International Development, Harvard University), Science, Technology and Innovation discussion paper no. 12.
   Google Scholar
• Waning, B.Diedrichsen, E.Moon, S. (2010), ‘A Lifeline to Treatment: The Role of Indian Generic Manufacturers in Supplying Antiretroviral Medicines to Developing Countries’, Journal of International AIDS Society, 13 (1), pp. 35–44. doi: 10.1186/1758-2652-13-35
   PubMedGoogle Scholar
• WDR (World Bank World Development Report) (1991), World Development Report 1991: The Challenge of Development (Washington, DC: World Bank).
   Google Scholar
• WDR (2005), World Development Report 2005: A Better Investment Climate for Everyone (Washington, DC: World Bank).
   Google Scholar
• World Trade Organization (WTO) (1994), Agreement on Trade-Related Aspects of Intellectual Property Rights. Annex 1C. (Geneva: World Trade Organization). Available from: http://www.wto.org/english/docs_e/legal_e/27-trips.pdf [accessed 11 October 2012].
   Google Scholar
• WTO (2001), ‘Declaration on the TRIPs Agreement and Public Health’, Ministerial Conference on Public Health, Doha, 9–14 November. Available from: http://www.who.int/medicines/areas/policy/tripshealth.pdf [accessed 5 October 2012].
   Google Scholar